Making personalised healthcare accessible to all Australians by harnessing the collective skills and expertise of industry to accelerate the adoption of genomics
INDEPENDENT. TRUSTED. CREDIBLE.
InGeNA
OUR PURPOSE:
InGeNA is a united voice for Australian industry partners contributing our skills and expertise to the rapidly developing field of genomics and advancing precision health in Australia.
InGeNA
About us
InGeNA the industry voice for the future of genomics and precision medicine in Australia
Members
Strategy
The time is now.
Realising the full potential of genomics to personalise healthcare is a compelling vision, but now the real work begins in how to implement it.
InGeNA was established to help bring the vision of precision health to fruition, where Australian citizens are the beneficiaries of a health system that has fully integrated genomics into its DNA, delivering better outcomes for patients and the population.
Partners
InGeNA News
Webinar: NAGIM Implementations
The first InGeNA webinar for the year will be themed ‘NAGIM Implementations’. The National Approach to Genomic Information Management (NAGIM) seeks a national genomic data asset for Australia, within a seamless and secure digital genomics ecosystem. A NAGIM is founded...
Rare Disease Day
More than 300 million people worldwide and two million Australians live with rare disease, and 72% of rare diseases are genetic. This internationally recognised day of awareness has been building support for the rare disease community since 2008 and calls for...
2025 Newsletters
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Get involved
InGeNA partners with organisations in research, peak bodies, government, member organisations, and non-profits that share our vision of realising the full potential of genomics to personalise healthcare.
InGeNA can offer support to projects in the form of letters of support and connections to our members and broader network.





















































